genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2021
Ovarian cancer
Cancer
Cryo-EM Advances Breast and Ovarian Cancer Research
Bioprocessing
BioVaxys and BioElpida Sign Ovarian Cancer Drug Manufacturing Deal
Cancer
New End-Trimming Activity Revealed in Key Enzyme for Cancer Growth
Cancer
Glutamine Dependence of Chemotherapy-Resistant Ovarian Cancer Holds Therapeutic Potential
Genome Editing
Using RNAi and CRISPR Screening to Elucidate Biological Pathways
Cancer
3D Tumor Model May Lead to Improved Ovarian Cancer Treatment
Insights
Rosalind Franklin the Scientist
Cancer
Ovarian Cancer Cells’ Dependence on Fat Opens up Potential New Treatment
Cancer
Ovarian Cancer Drug Resistance Protein Identified
Cancer
ImmunoGen Axing Nearly 75% of Workforce, Shrinking Pipeline and Facilities
1
...
3
4
5
...
29
Page 4 of 29
Scroll Up